PensionDanmark’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.29M Buy
14,500
+740
+5% +$132K 0.03% 397
2026
Q1
$2.37M Sell
13,760
-1,740
-11% -$323K 0.02% 438
2025
Q4
$3.09M Buy
+15,500
New +$2.81M 0.03% 404

Other funds holding CRL

PensionDanmark's CRL Position: Q2 2026 in Review

PensionDanmark increased its Charles River Laboratories (CRL) stake by 5.4% in Q2 2026, buying an estimated $132K and bringing the position to 14,500 shares worth $3.29M. The position accounts for 0.03% of the portfolio, ranked #397.

PensionDanmark first reported a position in CRL in Q4 2025 and has held it in 3 quarters since. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • PensionDanmark held 14,500 shares of Charles River Laboratories worth $3.29M as of Q2 2026.
  • PensionDanmark bought 740 Charles River Laboratories shares in Q2 2026, an estimated $132K.
  • Charles River Laboratories made up 0.03% of PensionDanmark's portfolio in Q2 2026, its #397 holding.
  • PensionDanmark first reported a position in Charles River Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on PensionDanmark's 13F filing for Q2 2026, filed 8 Jul 2026.